相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Immunological Aspects of Antiviral Therapy of Chronic Hepatitis B Virus and Hepatitis C Virus Infections
Barbara Rehermann et al.
HEPATOLOGY (2015)
Genetic variations in STAT4, C2, HLA-DRB1 and HLA-DQ associated with risk of hepatitis B virus-related liver cirrhosis
De-Ke Jiang et al.
SCIENTIFIC REPORTS (2015)
Association of IL28B polymorphisms with peginterferon treatment response in Chinese Han patients with HBeAg-positive chronic hepatitis B
Haiqing Wu et al.
LIVER INTERNATIONAL (2015)
Systematic review with meta-analysis: do interferon lambda 3 polymorphisms predict the outcome of interferon-therapy in hepatitis B infection?
E. Galmozzi et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2014)
Effect of HLA-DP and IL28B gene polymorphisms on response to interferon treatment in hepatitis B e-antigen seropositive chronic hepatitis B patients
Lin Cheng et al.
HEPATOLOGY RESEARCH (2014)
Hepatitis B virus infection
Christian Trepo et al.
LANCET (2014)
IL28B polymorphisms predict interferon-related hepatitis B surface antigen seroclearance in genotype D hepatitis B e antigen-negative patients with chronic hepatitis B
Pietro Lampertico et al.
HEPATOLOGY (2013)
One more piece in the interleukin 28B gene puzzle? The case of hepatitis B
Nikolaus Jilg et al.
HEPATOLOGY (2013)
IL28B genotype is not useful for predicting treatment outcome in Asian chronic hepatitis B patients treated with pegylated interferon-α
Jacinta A. Holmes et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2013)
Differential boosting of innate and adaptive antiviral responses during pegylated-interferon-alpha therapy of chronic hepatitis B
Lorenzo Micco et al.
JOURNAL OF HEPATOLOGY (2013)
Genetic variants in STAT4 and HLA-DQ genes confer risk of hepatitis B virus-related hepatocellular carcinoma
De-Ke Jiang et al.
NATURE GENETICS (2013)
A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus
Ludmila Prokunina-Olsson et al.
NATURE GENETICS (2013)
Evaluation of susceptibility locus for response to interferon-α based therapy in chronic hepatitis B patients in Chinese
Xiaopan Wu et al.
ANTIVIRAL RESEARCH (2012)
Effectiveness of Hepatitis B Treatment in Clinical Practice
Steven J. Scaglione et al.
GASTROENTEROLOGY (2012)
Polymorphisms Near IL28B and Serologic Response to Peginterferon in HBeAg-Positive Patients With Chronic Hepatitis B
Milan J. Sonneveld et al.
GASTROENTEROLOGY (2012)
New perspectives in the therapy of chronic hepatitis B
Pietro Lampertico et al.
GUT (2012)
Clinical utility of interleukin-28B testing in patients with genotype 1
Michelle Lai et al.
HEPATOLOGY (2012)
Genetics of IL28B and HCV-response to infection and treatment
C. Nelson Hayes et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2012)
Genetic variation in IL28B and treatment outcome in HBeAg-positive and -negative chronic hepatitis B patients treated with Peg interferon alfa-2a and adefovir
A. de Niet et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2012)
Effect of host and viral factors on hepatitis B e antigen-positive chronic hepatitis B patients receiving pegylated interferon-alpha-2a therapy
Tai-Chung Tseng et al.
ANTIVIRAL THERAPY (2011)
STAT4 associates with systemic lupus erythematosus through two independent effects that correlate with gene expression and act additively with IRF5 to increase risk
A-K Abelson et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
Factors That Predict Response of Patients With Hepatitis B e Antigen-Positive Chronic Hepatitis B to Peginterferon-Alfa
Erik H. C. J. Buster et al.
GASTROENTEROLOGY (2009)
Hepatitis B Virus Surface Antigen Levels: A Guide to Sustained Response to peginterferon alfa-2a in HBeAg-Negative Chronic Hepatitis B
Maurizia Rossana Brunetto et al.
HEPATOLOGY (2009)
Benefits and Risks of Interferon Therapy for Hepatitis B
Robert Perrillo
HEPATOLOGY (2009)
Cutting Edge: Autoimmune Disease Risk Variant of STAT4 Confers increased Sensitivity to IFN-alpha in Lupus Patients In Vivo
Silvia N. Kariuki et al.
JOURNAL OF IMMUNOLOGY (2009)
Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance
Dongliang Ge et al.
NATURE (2009)
IL28B is associated with response to chronic hepatitis C interferon-α and ribavirin therapy
Vijayaprakash Suppiah et al.
NATURE GENETICS (2009)
Genome-wide association of IL28B with response to pegylated interferon-α and ribavirin therapy for chronic hepatitis C
Yasuhito Tanaka et al.
NATURE GENETICS (2009)
STATs in cancer inflammation and immunity: a leading role for STAT3
Hua Yu et al.
NATURE REVIEWS CANCER (2009)
A risk haplotype of STAT4 for systemic lupus erythematosus is over-expressed, correlates with anti-dsDNA and shows additive effects with two risk alleles of IRF5
Snaevar Sigurdsson et al.
HUMAN MOLECULAR GENETICS (2008)
Interferon-inducible antiviral effectors
Anthony J. Sadler et al.
NATURE REVIEWS IMMUNOLOGY (2008)
Predicting response to peginterferon α-2a, lamivudine and the two combined for HBeAg-negative chronic hepatitis B
F. Bonino et al.
GUT (2007)
Peginterferon alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B
GKK Lau et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised
HLA Janssen et al.
LANCET (2005)
Regulation of JAK-STAT signalling in the immune system
K Shuai et al.
NATURE REVIEWS IMMUNOLOGY (2003)
Critical role for STAT4 activation by type 1 interferons in the interferon-γ response to viral infection
KB Nguyen et al.
SCIENCE (2002)
分享论文
